Pleiotropic activity of antihypertensives in atherothrombogenesis. Nebivolol: increasing possibilities and reducing restrictions
The review is devoted to the recent European recommendations' view on antihypertensive medications (AHM). The role of beta-adrenoblockers (BAB) in treating arterial hypertension (AH) patients is emphasized. Existing differences in pharmacological parameters and clinical effects are discussed fo...
Saved in:
Main Author: | M. G. Bubnova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2008-12-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1641 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
URODYNAMIC EFFECTS OF BETA-ADRENOBLOCKERS: NEBIVOLOL ADVANTAGES
by: M. P. Savenkov, et al.
Published: (2016-01-01) -
THE PLACE OF NEBIVOLOL IN RATIONAL THERAPY OF CONGESTIVE HEART FAILURE
by: A. B. Khadzegova
Published: (2014-09-01) -
Combination antihypertensive therapy in patients with arterial hypertension and coronary heart disease
by: T. E. Morozova, et al.
Published: (2013-08-01) -
Benefits of vasodilating beta-adrenoblockers for arterial hypertension treatment
by: V. B. Mychka
Published: (2012-06-01) -
NEBIVOLOL and the 2009 ESH update to the 2007 ESH/ESC Guidelines
by: V. I. Makolkin
Published: (2010-12-01)